AVCN.TO
Avicanna Inc
Price:  
0.15 
CAD
Volume:  
136,438.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2026-04-19, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -11.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 18.39 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -1.63 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.15 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-17 -11.30
2026-04-16 -11.30
2026-04-15 -11.30
2026-04-14 -11.30
2026-04-13 -10.91
2026-04-10 -11.30
2026-04-09 -11.30
2026-04-08 -11.30
2026-04-07 -11.30
2026-04-06 -11.30
2026-04-02 -11.30
2026-04-01 -11.30
2026-03-31 -11.30
2026-03-30 -11.30
2026-03-27 -11.30
2026-03-26 -12.46
2026-03-25 -11.69
2026-03-24 -12.84
2026-03-23 -12.84
2026-03-20 -12.07
2026-03-19 -12.46
2026-03-18 -12.07
2026-03-13 -13.23
2026-03-12 -13.62
2026-03-11 -13.62
2026-03-10 -14.00
2026-03-09 -14.00
2026-03-06 -14.00
2026-03-05 -14.00
2026-03-04 -14.00
2026-03-03 -14.39
2026-03-02 -14.00
2026-02-27 -13.62
2026-02-26 -13.62
2026-02-25 -13.23
2026-02-24 -12.84
2026-02-20 -12.84
2026-02-19 -12.84
2026-02-18 -12.84
2026-02-17 -13.62
2026-02-13 -12.84
2026-02-12 -12.46
2026-02-11 -13.23
2026-02-10 -13.62
2026-02-09 -12.84
2026-02-06 -13.62
2026-02-05 -14.39
2026-02-04 -14.00
2026-02-03 -14.77
2026-02-02 -14.39